Scheltens P, Blennow K, Breteler MM, de Strooper B, Frisoni GB, Salloway S, Van der Flier WM. Alzheimer’s disease. Lancet. 2016;388:505–17.
Article
CAS
Google Scholar
Masters CL, Bateman R, Blennow K, Rowe CC, Sperling RA, Cummings JL. Alzheimer’s disease. Nat Rev Dis Primers. 2015;1:15056.
Article
Google Scholar
Selkoe DJ. Cell biology of protein misfolding: The examples of Alzheimer´s and Parkinson´s diseases Nature Cell Biology 2004;6:1054–61.
Article
CAS
Google Scholar
Pearson HA, Peers C. Physiological roles for amyloid beta peptides. J Physiol. 2006;575:5–10.
Article
CAS
Google Scholar
Shirwany NA, Payette D, Xie J, Guo Q. The amyloid beta ion channel hypothesis of Alzheimer’s disease. Neuropsychiatr Dis Treat. 2007;3:597–612.
CAS
PubMed
PubMed Central
Google Scholar
Walker LC, Schelle J, Jucker M. The Prion-Like Properties of Amyloid-beta Assemblies: Implications for Alzheimer's Disease. Cold Spring Harb Perspect Med. 2016;6:1–16.
Article
Google Scholar
Braak H, Alafuzoff I, Arzberger T, Kretzschmar H, Del Tredici K. Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry. Acta Neuropathol. 2006;112:389–404.
Article
Google Scholar
Eisele YS, Duyckaerts C. Propagation of Ass pathology: hypotheses, discoveries, and yet unresolved questions from experimental and human brain studies. Acta Neuropathol. 2016;131:5–25.
Article
CAS
Google Scholar
Morales R, Duran-Aniotz C, Castilla J, Estrada LD, Soto C. De novo induction of amyloid-beta deposition in vivo. Mol Psychiatry. 2012;17:1347–53.
Article
CAS
Google Scholar
Kane MD, Lipinski WJ, Callahan MJ, Bian F, Durham RA, Schwarz RD, Roher AE, Walker LC. Evidence for seeding of b-amyloid by intracerebral infusion of Alzheimer brain extracts in β-amyloid precursor protein transgenic mice. J Neurosci. 2000;20:3606–11.
Article
CAS
Google Scholar
Meyer-Luehmann M. Exogenous induction of cerebral -amyloidogenesis is governed by agent and host. Science. 2006;313:1781–4.
Article
CAS
Google Scholar
Watts JC, Giles K, Grillo SK, Lemus A, DeArmond SJ, Prusiner SB. Bioluminescence imaging of Aβ deposition in bigenic mouse models of Alzheimer’s disease. Proc Natl Acad Sci. 2010;108:2528–33.
Article
Google Scholar
Ridley RM, Baker HF, Windle CP, Cummings RM. Very long term studies of the seeding of beta-amyloidosis in primates. J Neural Transm. 2006;113:1243–51.
Article
CAS
Google Scholar
Wesen E, Jeffries GDM, Matson Dzebo M, Esbjorner EK. Endocytic uptake of monomeric amyloid-beta peptides is clathrin- and dynamin-independent and results in selective accumulation of Abeta(1-42) compared to Abeta(1-40). Sci Rep. 2017;7:2021.
Article
Google Scholar
Guo JL, Lee VM. Cell-to-cell transmission of pathogenic proteins in neurodegenerative diseases. Nat Med. 2014;20:130–8.
Article
CAS
Google Scholar
Adav SS, Gallart-Palau X, Tan KH, Lim SK, Tam JP, Sze SK. Dementia-linked amyloidosis is associated with brain protein deamidation as revealed by proteomic profiling of human brain tissues. Mol Brain. 2016;9:20.
Article
Google Scholar
Izco M, Pesini P, Perez-Grijalba V, Fandos N, Sarasa M. Optimized protocol for amyloid-beta extraction from the brain. J Alzheimers Dis. 2013;34:835–9.
Article
CAS
Google Scholar
Roher A, Wolfe D, Palutke M, Kukuruga AD. Purification, ultrastructure, and chemical analysis of Alzheimer disease amyloid plaque core protein. Proc Natl Acad Sci. 1986;83:2662–6.
Article
CAS
Google Scholar
Diner I, Nguyen T, Seyfried NT. Enrichment of detergent-insoluble protein aggregates from human postmortem brain. J Vis Exp. 2017;128:e55835.
Tsuji TS, S. Kamiya, S. Sazuka, T. Ohara, O.: Analysis of brain proteins in Alzheimer’s disease using high-resolution two-dimensional gel electrophoresis. J Neurol Sci 1999, 166:100–106.
Article
CAS
Google Scholar
Tsuji TS. Analysis of the proteomic profiling of brain tissue in Alzheimer’s disease. Dis Markers. 2001;17:247–57.
Article
CAS
Google Scholar
Rostagno A, Ghiso J. Isolation and biochemical characterization of amyloid plaques and paired helical filaments. Curr Protoc Cell Biol. 2009; Chapter 3:Unit 3:1–31.
Hadley KC, Rakhit R, Guo H, Sun Y, Jonkman JE, McLaurin J, Hazrati LN, Emili A, Chakrabartty A. Determining composition of micron-scale protein deposits in neurodegenerative disease by spatially targeted optical microproteomics. eLife. 2015;4.
Hondius DC, van Nierop P, Li KW, Hoozemans JJ, van der Schors RC, van Haastert ES, van der Vies SM, Rozemuller AJ, Smit AB. Profiling the human hippocampal proteome at all pathologic stages of Alzheimer’s disease. Alzheimers Dement. 2016;12:654–68.
Article
Google Scholar
Liao L, Cheng D, Wang J, Duong DM, Losik TG, Gearing M, Rees HD, Lah JJ, Levey AI, Peng J. Proteomic characterization of postmortem amyloid plaques isolated by laser capture microdissection. J Biol Chem. 2004;279:37061–37,068.
Article
CAS
Google Scholar
Drummond E, Nayak S, Faustin A, Pires G, Hickman RA, Askenazi M, Cohen M, Haldiman T, Kim C, Han X, et al. Proteomic differences in amyloid plaques in rapidly progressive and sporadic Alzheimer’s disease. Acta Neuropathol. 2017;133:933–54.
Article
CAS
Google Scholar
Paxinos G, Franklin K. The mouse brain in stereotaxic coordinates. San Diego: Elsevier; 2008.
Google Scholar
Ubeda-Banon I, Saiz-Sanchez D, de la Rosa-Prieto C, Argandona-Palacios L, Garcia-Munozguren S, Martinez-Marcos A. alpha-Synucleinopathy in the human olfactory system in Parkinson’s disease: involvement of calcium-binding protein- and substance P-positive cells. Acta Neuropathol. 2010;119:723–35.
Article
CAS
Google Scholar
Saiz-Sanchez D, Flores-Cuadrado A, Ubeda-Banon I, de la Rosa-Prieto C, Martinez-Marcos A. Interneurons in the human olfactory system in Alzheimer’s disease. Exp Neurol. 2016;276:13–21.
Article
CAS
Google Scholar
Villar M, Ayllon N, Alberdi P, Moreno A, Moreno M, Tobes R, Mateos-Hernandez L, Weisheit S, Bell-Sakyi L, de la Fuente J. Integrated metabolomics, transcriptomics and proteomics identifies metabolic pathways affected by Anaplasma phagocytophilum infection in tick cells. Mol Cell Proteomics. 2015;14:3154–72.
Eden E, Navon R, Steinfeld I, Lipson D, Yakhini Z. GOrilla: a tool for discovery and visualization of enriched GO terms in ranked gene lists. BMC Bioinformatics. 2009;10:48.
Article
Google Scholar
Witztum J, Persi E, Horn D, Pasmanik-Chor M, Chor B. Hierarchical partitioning of metazoan protein conservation profiles provides new functional insights. PLoS One. 2014;9:e90282.
Article
Google Scholar
Ping L, Duong DM, Yin L, Gearing M, Lah JJ, Levey AI, Seyfried NT. Global quantitative analysis of the human brain proteome in Alzheimer’s and Parkinson’s disease. Sci Data. 2018;5:180036.
Article
CAS
Google Scholar
Gouwens LK, Makoni NJ, Rogers VA, Nichols MR. Amyloid-beta42 protofibrils are internalized by microglia more extensively than monomers. Brain Res. 2016;1648:485–95.
Article
CAS
Google Scholar
Kim J, Basak JM, Holtzman DM. The role of apolipoprotein E in Alzheimer’s disease. Neuron. 2009;63:287–303.
Article
CAS
Google Scholar
Eberhad DA, Brown MD, VandenBerg SR. Alterations of Annexin expression in pathological neuronal and glial reactions. Am J Pathol. 1994;145:640–8.
Google Scholar
Zhang C-C, Zhu J-X, Wan Y, Tan L, Wang H-F, yU J-T, Tan L. Meta-analysis of the association between variants in MAPT and neurodegenerative diseases. Oncotarget. 2017;8:44994–45,007.
PubMed
PubMed Central
Google Scholar
Vasavada MM, Wang J, Eslinger PJ, Gill DJ, Sun X, Karunanayaka P, Yang QX. Olfactory cortex degeneration in alzheimer’s disease and mild cognitive impairment. J Alzheimers Dis. 2015;45:947–58.
Article
Google Scholar
Kamphuis W, Middeldorp J, Kooijman L, Sluijs JA, Kooi EJ, Moeton M, Freriks M, Mizee MR, Hol EM. Glial fibrillary acidic protein isoform expression in plaque related astrogliosis in Alzheimer’s disease. Neurobiol Aging. 2014;35:492–510.
Article
CAS
Google Scholar
Gozal YM, Duong DM, Gearing M, Cheng D, Hanfelt JJ, Funderburk C, Peng J, Lah JJ, Levey AI. Proteomics analysis reveals novel components in the detergent-insoluble subproteome in Alzheimer’s disease. J Proteome Res. 2009;8:5069–79.
Article
CAS
Google Scholar
Jimenez S, Navarro V, Moyano J, Sanchez-Mico M, Torres M, Davila JC, Vizuete M, Gutierrez A, Vitorica J. Disruption of amyloid plaques integrity affects the soluble oligomers content from Alzheimer disease brains. PloS one. 2014;9:e114041.
Article
Google Scholar
Davies CA, Mann DMA. Is the “preamyloid” of diffuse plaques in Alzheimer’s disease really nonfibrillar? Am J Pathol. 1993;143:1594–605.
CAS
PubMed
PubMed Central
Google Scholar
Esparza TJ, Wildburger NC, Jiang H, Gangolli M, Cairns NJ, Bateman RJ, Brody DL. Soluble amyloid-beta aggregates from human Alzheimer’s disease brains. Sci Rep. 2016;6:38187.
Article
CAS
Google Scholar
Salter MW, Stevens B. Microglia emerge as central players in brain disease. Nat Med. 2017;23:1018–27.
Article
CAS
Google Scholar
Hol EM, Roelofs RF, Moraal E, Sonnemans MAF, Sluijs JA, Proper EA, de Graan PNE, Fischer DF, van Leeuwen FW. Neuronal expression of GFAP in patients with Alzheimer pathology and identification of novel GFAP splice forms. Mol Psychiatry. 2003;8:786–96.
Article
CAS
Google Scholar
Sohma H, Imai S, Takei N, Honda H, Matsumoto K, Utsumi K, Matsuki K, Hashimoto E, Saito T, Kokai Y. Evaluation of annexin A5 as a biomarker for Alzheimer’s disease and dementia with Lewy bodies. Front Aging Neurosci. 2013;5:15.
Article
CAS
Google Scholar
Yamaguchi M, Kokai Y, Imai S, Utsumi K, Matsumoto K, Honda H, Mizue Y, Momma M, Maeda T, Toyomasu S, et al. Investigation of annexin A5 as a biomarker for Alzheimer’s disease using neuronal cell culture and mouse model. J Neurosci Res. 2010;88:2682–92.
CAS
PubMed
Google Scholar
Frere S, Slutsky I. Alzheimer’s disease: from firing instability to homeostasis network collapse. Neuron. 2018;97:32–58.
Article
CAS
Google Scholar
Minjarez B, Calderon-Gonzalez KG, Rustarazo ML, Herrera-Aguirre ME, Labra-Barrios ML, Rincon-Limas DE, Del Pino MM, Mena R, Luna-Arias JP. Identification of proteins that are differentially expressed in brains with Alzheimer’s disease using iTRAQ labeling and tandem mass spectrometry. J Proteomics. 2016;139:103–21.
Article
CAS
Google Scholar
Potempska A, Ramakrishna N, wisniewski HM, Miller DL. Interaction between the β-amyloid peptide precursor and histones. Arch Biochem Biophys. 1993;204:448–53.
Article
Google Scholar
Xu J, Zhang X, Pelayo R, Monestier M, Ammollo CT, Semeraro F, Taylor FB, Esmon NL, Lupu F, Esmon CT. Extracellular histones are major mediators of death in sepsis. Nat Med. 2009;15:1318–21.
Article
CAS
Google Scholar
Chen R, Kang R, Fan XG, Tang D. Release and activity of histone in diseases. Cell Death Dis. 2014;5:e1370.
Article
CAS
Google Scholar
Thomsen MS, Routhe LJ, Moos T. The vascular basement membrane in the healthy and pathological brain. J Cereb Blood Flow Metab. 2017;37:3300–17.
Article
Google Scholar
Morris AW, Carare RO, Schreiber S, Hawkes CA. The cerebrovascular basement membrane: role in the clearance of beta-amyloid and cerebral amyloid angiopathy. Front Aging Neurosci. 2014;6:251.
Article
Google Scholar
Cheng JS, Dubal DB, Kim DH, Legleiter J, Cheng IH, Yu GQ, Tesseur I, Wyss-Coray T, Bonaldo P, Mucke L. Collagen VI protects neurons against Abeta toxicity. Nat Neurosci. 2009;12:119–21.
Article
CAS
Google Scholar
Cescon M, Chen P, Castagnaro S, Gregorio I, Bonaldo P. Lack of collagen VI promotes neurodegeneration by impairing autophagy and inducing apoptosis during aging. Aging. 2016;8:1083–98.
Article
CAS
Google Scholar
Bai Z, Stamova B, Xu H, Ander BP, Wang J, Jickling GC, Zhan X, Liu D, Han G, Jin LW, et al. Distinctive RNA expression profiles in blood associated with Alzheimer disease after accounting for white matter hyperintensities. Alzheimer Dis Assoc Disord. 2014;28:226–33.
Article
CAS
Google Scholar
Morimoto T, Enmi JI, Hattori Y, Iguchi S, Saito S, Harada KH, Okuda H, Mineharu Y, Takagi Y, Youssefian S, et al. Dysregulation of RNF213 promotes cerebral hypoperfusion. Sci Rep. 2018;8:3607.
Article
Google Scholar
Farkas E, Luiten PG. Cerebral microvascular pathology in aging and Alzheimer’s disease. Prog Neurobiol. 2001;64:575–611.
Article
CAS
Google Scholar
Medway C, Shi H, Bullock J, Black H, Brown K, Vafadar-isfahani B, Matharoo-ball B, Ball G, Rees R, Kalsheker N, Morgan K. Using in silico LD clumping and meta-analysis of genome-wide datasets as a complementary tool to investigate and validate new candidate biomarkers in Alzheimer’s disease. Int J Mol Epidemiol Genetics. 2010;1:133–44.
Google Scholar
Gulisano W, Bizzoca A, Gennarini G, Palmeri A, Puzzo D. Role of the adhesion molecule F3/Contactin in synaptic plasticity and memory. Mol Cell Neurosci. 2017;81:64–71.
Article
CAS
Google Scholar
Gabel M, Delavoide F, Royer C, Tahouly T, Gasman S, Bader MF, Vitale N, Golaz S. Phosphorylation cycling of Annexin A2 Tyr23 is critical for calcium-regulated exocytosis in neuroendocrine cells. Biochimica et Biophysica Acta (BBA) - Mol Cell Res. 2019;7:1207–17.
Article
Google Scholar
Huber R, Schneider M, Mayr I, Romisch J, Paques EP. The calcium binding sites in human annexin V by crystal structure analysis at 2.0 A resolution Implications for membrane binding and calcium channel activity. FEBS Lett. 1990;275:15–21.
Article
CAS
Google Scholar
Amphlett GW, Hrinda ME. The binding of calcium to human fibronectin. Biochem Biophys Res Commun. 1983;111:1045–53.
Article
CAS
Google Scholar
Quill B, Rnaten M, Docherty NG, McElnea EM, Wallace DM, Clark AF, O’Brien CJ. Calcium channel blockade reduces mechanical strain-induced extracellular matrix gene response in lamina cribrosa cells. Br J Ophthalmol. 99:1009–14.
Article
CAS
Google Scholar
Wang Y, Shi Y, Wei H. Calcium Dysregulation in Alzheimer's Disease: A Target for New Drug Development. J Alzheimers Dis Parkinsonism. 2017;7:1–15.
Penke B, Bogar F, Fulop L. β-Amyloid and the Pathomechanisms of Alzheimer's Disease: A Comprehensive View. Molecules. 2017;22:1–32.
Article
Google Scholar
Mai JK, Paxino G, Voss T. Atlas of the human brain. San Diego: Press EA; 2008.
Google Scholar